Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + Gemcitabine in Advanced Pancreatic Cancer
NCT00179751Phase 2Terminated
- Sponsor
- Celgene Corporation
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in pancreatic carcinoma, sponsored by Celgene Corporation. Started Apr 2005; status: terminated.
02
Drugs
lenalidomide
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT00179751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179751.